Compass Wealth Management LLC Invests $992,000 in SPDR S&P Pharmaceuticals ETF $XPH

Compass Wealth Management LLC acquired a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the 4th quarter, Holdings Channel reports. The firm acquired 17,707 shares of the company’s stock, valued at approximately $992,000.

Several other large investors also recently made changes to their positions in the business. Envestnet Asset Management Inc. acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth $10,732,000. LPL Financial LLC increased its position in shares of SPDR S&P Pharmaceuticals ETF by 13.2% in the fourth quarter. LPL Financial LLC now owns 207,649 shares of the company’s stock worth $11,630,000 after acquiring an additional 24,252 shares in the last quarter. Envestnet Portfolio Solutions Inc. increased its position in shares of SPDR S&P Pharmaceuticals ETF by 2.0% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 175,309 shares of the company’s stock worth $9,819,000 after acquiring an additional 3,379 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of SPDR S&P Pharmaceuticals ETF by 96.9% in the first quarter. Goldman Sachs Group Inc. now owns 119,929 shares of the company’s stock worth $5,253,000 after acquiring an additional 59,007 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its position in shares of SPDR S&P Pharmaceuticals ETF by 123.8% in the fourth quarter. BNP Paribas Financial Markets now owns 89,500 shares of the company’s stock worth $5,013,000 after acquiring an additional 49,500 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Up 0.1%

SPDR S&P Pharmaceuticals ETF stock opened at $58.36 on Thursday. SPDR S&P Pharmaceuticals ETF has a 52-week low of $40.26 and a 52-week high of $60.73. The firm has a fifty day moving average of $57.32 and a 200-day moving average of $56.27. The firm has a market capitalization of $358.91 million, a P/E ratio of 14.28 and a beta of 0.61.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.